The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label that the drug can also reduce the risk of heart events by 20% in people with obesity , for example.

However, these benefits did not come without risks, the researchers observed. For example, GLP-1RAs also increased people's odds of developing gastrointestinal issues such as abdominal pain (12% ...

The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.

You've probably heard of medications like Ozempic, Wegovy and Zeptide. They're a class of prescription drugs that are increasingly popular. In fact, one in eight U.S. adults reported using a GLP-1 ...

A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

Almonds, pistachios, and walnuts may help boost GLP-1 thanks to their fiber, protein, and healthy fats. These nutrients work ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Different types of foods provide different omega-3 fatty acids. The first two types, EPA and DHA, are abundant in fish, which is why they're commonly called "marine omega-3s." ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...